Unresolved compliance issues at a manufacturing plant operated by Novo Nordisk have led to a complete response letter for Scholar Rock's lead drug for spinal muscular atrophy (SMA). The CRL is related ...
Micron Technology’s AI-driven memory growth is limited by HBM supply and valuation premium. Know the risks, cycle timing, and why analysts rate MU stock a Hold.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback